Can genomic medicine improve financial sustainability of health systems?

Recent years have seen increased use of genomic technologies in a variety of research and clinical settings. Genomic medicine is not a cost-containment measure per se, but is viewed as having the potential to bend the healthcare cost curve. Currently, it is unknown how systematic adoption of genomic medicine in clinical practice will impact healthcare costs. This article discusses the potential economic impact of genomic medicine and the challenges that lie ahead.

Investigators
Abbreviation
Mol Diagn Ther
Publication Date
2015-04-11
Volume
19
Issue
2
Page Numbers
71-7
Pubmed ID
25862552
Medium
Print
Full Title
Can genomic medicine improve financial sustainability of health systems?
Authors
Lu CY, Cohen JP